Clinical Trial Update: Study of CHS-114 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating CHS-114 in participants with advanced solid tumors, including head and neck squamous cell carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Solid Tumors

Drugs mentioned

• CHS-114

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING